Legend Biotech’s $403 Million Shares Offering

Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation.Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000 American…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here